BAILARD, INC. - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 62 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2019. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q1 2019$816,000
-1.3%
228,000
+5.6%
0.05%
-8.9%
Q4 2018$827,000
+24.9%
216,000
+208.6%
0.06%
+43.6%
Q3 2018$662,000
-10.5%
70,000
-67.4%
0.04%
-42.6%
Q3 2016$740,000
-1.1%
215,0000.0%0.07%
-23.6%
Q2 2016$748,000
-15.8%
215,0000.0%0.09%
-28.2%
Q1 2016$888,000
-32.2%
215,0000.0%0.12%
-39.2%
Q3 2015$1,309,000215,0000.20%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2019
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders